ArticleBiomolecules2023

Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide.

Riaz Jannoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.